Literature DB >> 29316430

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Qianghu Wang, Baoli Hu, Xin Hu, Hoon Kim, Massimo Squatrito, Lisa Scarpace, Ana C deCarvalho, Sali Lyu, Pengping Li, Yan Li, Floris Barthel, Hee Jin Cho, Yu-Hsi Lin, Nikunj Satani, Emmanuel Martinez-Ledesma, Siyuan Zheng, Edward Chang, Charles-Etienne Gabriel Sauvé, Adriana Olar, Zheng D Lan, Gaetano Finocchiaro, Joanna J Phillips, Mitchel S Berger, Konrad R Gabrusiewicz, Guocan Wang, Eskil Eskilsson, Jian Hu, Tom Mikkelsen, Ronald A DePinho, Florian Muller, Amy B Heimberger, Erik P Sulman, Do-Hyun Nam, Roel G W Verhaak.   

Abstract

Entities:  

Year:  2018        PMID: 29316430      PMCID: PMC5892424          DOI: 10.1016/j.ccell.2017.12.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  70 in total

1.  MicroRNA-34a inhibits bladder cancer cell migration and invasion, and upregulates PTEN expression.

Authors:  Zhen-Shan Ding; Yu-Hui He; Yi-Sen Deng; Pan-Xin Peng; Jian-Feng Wang; Xing Chen; Pei-Yu Zhao; Xiao-Feng Zhou
Journal:  Oncol Lett       Date:  2019-09-18       Impact factor: 2.967

2.  Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma.

Authors:  Chen Zhu; Cunyi Zou; Gefei Guan; Qing Guo; Zihao Yan; Tianqi Liu; Shuai Shen; Xiaoyan Xu; Chen Chen; Zhiguo Lin; Wen Cheng; Anhua Wu
Journal:  Oncoimmunology       Date:  2019-06-12       Impact factor: 8.110

Review 3.  Developmental origins and oncogenic pathways in malignant brain tumors.

Authors:  Q Richard Lu; Lily Qian; Xianyao Zhou
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-04-03       Impact factor: 5.814

Review 4.  Toward precision immunotherapy using multiplex immunohistochemistry and in silico methods to define the tumor immune microenvironment.

Authors:  Samuel S Widodo; Ryan A Hutchinson; Yitong Fang; Stefano Mangiola; Paul J Neeson; Phillip K Darcy; Alexander D Barrow; Christopher M Hovens; Marija Dinevska; Stanley S Stylli; Theo Mantamadiotis
Journal:  Cancer Immunol Immunother       Date:  2021-01-03       Impact factor: 6.968

5.  Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.

Authors:  Silvana Valdebenito; Daniela D'Amico; Eliseo Eugenin
Journal:  Cancer Rep (Hoboken)       Date:  2019-11-11

6.  Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.

Authors:  Ae Kyung Park; Pora Kim; Leomar Y Ballester; Yoshua Esquenazi; Zhongming Zhao
Journal:  Neuro Oncol       Date:  2019-01-01       Impact factor: 12.300

7.  1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.

Authors:  Yanyu Zhang; Yuan Xie; Liqun He; Jiefu Tang; Qiyuan He; Qingze Cao; Langjun Cui; Wei Guo; Kai Hua; Anna Dimberg; Liang Wang; Lei Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-09-11       Impact factor: 6.730

8.  The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.

Authors:  Johanna Klughammer; Barbara Kiesel; Thomas Roetzer; Nikolaus Fortelny; Amelie Nemc; Karl-Heinz Nenning; Julia Furtner; Nathan C Sheffield; Paul Datlinger; Nadine Peter; Martha Nowosielski; Marco Augustin; Mario Mischkulnig; Thomas Ströbel; Donat Alpar; Bekir Ergüner; Martin Senekowitsch; Patrizia Moser; Christian F Freyschlag; Johannes Kerschbaumer; Claudius Thomé; Astrid E Grams; Günther Stockhammer; Melitta Kitzwoegerer; Stefan Oberndorfer; Franz Marhold; Serge Weis; Johannes Trenkler; Johanna Buchroithner; Josef Pichler; Johannes Haybaeck; Stefanie Krassnig; Kariem Mahdy Ali; Gord von Campe; Franz Payer; Camillo Sherif; Julius Preiser; Thomas Hauser; Peter A Winkler; Waltraud Kleindienst; Franz Würtz; Tanisa Brandner-Kokalj; Martin Stultschnig; Stefan Schweiger; Karin Dieckmann; Matthias Preusser; Georg Langs; Bernhard Baumann; Engelbert Knosp; Georg Widhalm; Christine Marosi; Johannes A Hainfellner; Adelheid Woehrer; Christoph Bock
Journal:  Nat Med       Date:  2018-08-27       Impact factor: 53.440

9.  The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma.

Authors:  Khatri Latha; Jun Yan; Yuhui Yang; Loyola V Gressot; Ling-Yuan Kong; Ganiraju Manyam; Ravesanker Ezhilarasan; Qianghu Wang; Erik P Sulman; R Eric Davis; Suyun Huang; Gregory N Fuller; Arvind Rao; Amy B Heimberger; Shulin Li; Ganesh Rao
Journal:  J Natl Cancer Inst       Date:  2019-03-01       Impact factor: 13.506

Review 10.  Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.

Authors:  Kevin Beccaria; Aria Sabbagh; John de Groot; Michael Canney; Alexandre Carpentier; Amy B Heimberger
Journal:  J Neurooncol       Date:  2020-02-28       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.